These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8893268)

  • 21. Cys34-PEGylated Human Serum Albumin for Drug Binding and Delivery.
    Mehtala JG; Kulczar C; Lavan M; Knipp G; Wei A
    Bioconjug Chem; 2015 May; 26(5):941-9. PubMed ID: 25918947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of anthocyanins with human serum albumin: influence of pH and chemical structure on binding.
    Cahyana Y; Gordon MH
    Food Chem; 2013 Dec; 141(3):2278-85. PubMed ID: 23870958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of pH, temperature and protein concentration on the in vitro binding of flutamide to human serum albumin.
    Esmaeilzadeh S; Valizadeh H; Zakeri-Milani P
    Pharm Dev Technol; 2017 Dec; 22(8):982-991. PubMed ID: 27055586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite.
    Carballal S; Radi R; Kirk MC; Barnes S; Freeman BA; Alvarez B
    Biochemistry; 2003 Aug; 42(33):9906-14. PubMed ID: 12924939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the cysteine 34 residue in human serum albumin using fluorescence techniques.
    Narazaki R; Maruyama T; Otagiri M
    Biochim Biophys Acta; 1997 Apr; 1338(2):275-81. PubMed ID: 9128146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human serum albumin adsorption on hydrogel contact lenses in vitro.
    Garrett Q; Milthorpe BK
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2594-602. PubMed ID: 8977473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants.
    Gryzunov YA; Arroyo A; Vigne JL; Zhao Q; Tyurin VA; Hubel CA; Gandley RE; Vladimirov YA; Taylor RN; Kagan VE
    Arch Biochem Biophys; 2003 May; 413(1):53-66. PubMed ID: 12706341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum albumin as a primary non-covalent binding protein for nitro-oleic acid.
    Hernychova L; Alexandri E; Tzakos AG; Zatloukalová M; Primikyri A; Gerothanassis IP; Uhrik L; Šebela M; Kopečný D; Jedinák L; Vacek J
    Int J Biol Macromol; 2022 Apr; 203():116-129. PubMed ID: 35063491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations.
    Miyamura S; Imafuku T; Anraku M; Taguchi K; Yamasaki K; Tominaga Y; Maeda H; Ishima Y; Watanabe H; Otagiri M; Maruyama T
    J Pharm Sci; 2016 Mar; 105(3):1043-9. PubMed ID: 26928399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
    Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
    Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding and molecular dynamics studies of 7-hydroxycoumarin derivatives with human serum albumin and its pharmacological importance.
    Yeggoni DP; Gokara M; Manidhar DM; Rachamallu A; Nakka S; Reddy CS; Subramanyam R
    Mol Pharm; 2014 Apr; 11(4):1117-31. PubMed ID: 24495045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of two bromocresol purple binding sites on human serum albumin.
    Ito S; Yamamoto D
    Clin Chim Acta; 2010 Oct; 411(19-20):1536-8. PubMed ID: 20570667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the binding of an anticancer drug, lapatinib to human serum albumin.
    Kabir MZ; Mukarram AK; Mohamad SB; Alias Z; Tayyab S
    J Photochem Photobiol B; 2016 Jul; 160():229-39. PubMed ID: 27128364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipid hydroperoxide cysteine peroxidase activity of human serum albumin.
    Hurst R; Bao Y; Ridley S; Williamson G
    Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):723-8. PubMed ID: 10051445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring.
    Li H; Grigoryan H; Funk WE; Lu SS; Rose S; Williams ER; Rappaport SM
    Mol Cell Proteomics; 2011 Mar; 10(3):M110.004606. PubMed ID: 21193536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Tyr84 in controlling the reactivity of Cys34 of human albumin.
    Stewart AJ; Blindauer CA; Berezenko S; Sleep D; Tooth D; Sadler PJ
    FEBS J; 2005 Jan; 272(2):353-62. PubMed ID: 15654874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: spectroscopy and modelling.
    Gelamo EL; Silva CH; Imasato H; Tabak M
    Biochim Biophys Acta; 2002 Jan; 1594(1):84-99. PubMed ID: 11825611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imatinib binding to human serum albumin modulates heme association and reactivity.
    Di Muzio E; Polticelli F; Trezza V; Fanali G; Fasano M; Ascenzi P
    Arch Biochem Biophys; 2014 Oct; 560():100-12. PubMed ID: 25057771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cobalt-albumin binding assay: insights into its mode of action.
    Bar-Or D; Rael LT; Bar-Or R; Slone DS; Mains CW; Rao NK; Curtis CG
    Clin Chim Acta; 2008 Jan; 387(1-2):120-7. PubMed ID: 17964561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.